Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A
Kyoko Hashimoto(The University of Tokyo), Shingo Sato(Tokyo Institute of Psychiatry), Atsushi Okawa(Research Institute of Economy, Trade and Industry), Kenta Yao(Tokyo Medical and Dental University), Satoko Sunamura(Tokyo Medical and Dental University), Yo Mabuchi(Keio University), Chihiro Akazawa(Juntendo University), Mitsuru Futakuchi(Yamagata University), Shu Takeda(Toranomon Hospital), Hiroki Ochi(National Rehabilitation Center for Persons with Disabilities), Keisuke Ae(The Cancer Institute Hospital), Nobuyoshi Kosaka(Tokyo Medical University), Takahiro Ochiya(Unknown), Toru Fukuda(Saitama Medical University), Hiroaki Kanda(Saitama Cancer Center)
Cited by 264
Related Papers
Neutral Sphingomyelinase 2 (nSMase2)-dependent Exosomal Transfer of Angiogenic MicroRNAs Regulate Cancer Cell Metastasis
|Journal of Biological Chemistry|2013|770
Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood–brain barrier
|Nature Communications|2015|706
Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen
|Nature Communications|2014|595
Extracellular vesicles as biomarkers and therapeutic targets for cancer
|American Journal of Physiology-Cell Physiology|2019|412
MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL
|Cancer Cell|2005|388